Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
35.65
+0.58 (1.65%)
Oct 3, 2025, 4:00 PM EDT - Market closed

Inhibrx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22
516223--
Enterprise Value
43728--
Last Close Price
35.6515.40--
PE Ratio
-0.13--
PS Ratio
368.861114.65--
PB Ratio
7.531.67--
P/TBV Ratio
7.531.67--
EV/Sales Ratio
311.88142.16--
Debt / Equity Ratio
1.560.064.83-0.69
Asset Turnover
0.010.000.01-
Inventory Turnover
46.7334.2835.84-
Quick Ratio
4.823.764.950.01
Current Ratio
4.983.945.250.30
Return on Equity (ROE)
-113.71%1905.92%-1333.38%-
Return on Assets (ROA)
-26.29%-67.38%-84.42%-
Return on Capital (ROIC)
-31.17%-83.29%-108.99%-
Earnings Yield
-31.70%757.00%--
FCF Yield
-27.14%-88.37%--
Buyback Yield / Dilution
-13.93%-27.17%--
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q